First US all-cargo airline to earn CEIV certification
July 13, 2017Amerijet International, based in Fort Lauderdale, Florida, has announced that it has received the International Air Transport Association’s (IATA) CEIV-Pharma …
Gain insight into what your peers are doing
July 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, life sciences, pharma, pharmaceutical, wave
When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
UK Government boosts NHS cyber security with additional £21 million
July 13, 2017Medical Communications Cyber Security, Cyber attack, NHS, biotech, drugs, life sciences, pharma, pharmaceutical
The government has announced its response to Dame Fiona Caldicott’s 2016 data security review and in the wake of the …
Novartis’ breakthrough cancer treatment receives FDA advisory approval
July 13, 2017Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical
In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …
UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators
July 13, 2017Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical
The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …
AstraZeneca’s CEO set for shock switch to Teva
July 13, 2017Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical
It is no secret that Teva has been on the lookout for a new CEO and they had already been …
Ocular slapped with CRL despite last-ditch efforts
July 12, 2017Dextenza, Ocular Therapeutix, biotech, drugs, pharma, pharmaceutical
Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …
Enterome bolsters board with new executive appointment
July 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Enterome, biotech, drugs, healthcare, pharma, pharmaceuticals
Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …
Nabriva Therapeutics recruit new COO
July 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical
Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …
Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm
July 12, 2017Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals
Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
Stada takeover back in motion after revised bid
July 12, 2017Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …
Contaminated blood inquiry to probe thousands of deaths
July 12, 2017Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical
UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …
Investigational drug found to boost treatment efficacy in paediatric brain cancer
July 12, 2017Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical
Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …
Plot twist as FDA U-turns on Amicus drug decision
July 11, 2017Research and Development, Sales and Marketing Amicus Therapeutics, FDA, Galafold
The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …
Sanofi snatches up Protein Sciences for $750 million
July 11, 2017Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences
French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …
Hope in quest for gonorrhoea vaccination
July 11, 2017Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination
Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …
Ipsen secures NICE approval for multi-targeting kidney cancer therapy
July 11, 2017Manufacturing and Production, Sales and Marketing Cabometyx, Kidney cancer, NICE
Ipsen has announced that its therapy Cabometyx (cabozantinib) has been given approval by NICE for the treatment of advanced renal …
ABPI launches legal action to overturn £20m price cap
July 11, 2017Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE
When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
Brain tumours to be used to manufacture stem cells
July 10, 2017Manufacturing and Production, Research and Development Censo Biotechnologies, University of Leeds
Censo Biotechnologies has announced that it will collaborate with the University of Leeds to use the latest stem cell technology …
New director of CDC courts controversy from all angles
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US
It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
